Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(27%)
Results Posted
14%(1 trials)

Phase Distribution

Ph not_applicable
9
82%
Ph phase_1
1
9%
Ph phase_3
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(7)
Other(1)

Detailed Status

Completed7
Recruiting3
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (9.1%)
Phase 31 (9.1%)
N/A9 (81.8%)

Trials by Status

recruiting327%
suspended19%
completed764%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11